K2M Group Holdings, Inc. (KTWO) Shares Bought by Gabelli Funds LLC
Gabelli Funds LLC grew its stake in shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) by 28.0% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 18,300 shares of the medical device company’s stock after buying an additional 4,000 shares during the period. Gabelli Funds LLC’s holdings in K2M Group Holdings were worth $388,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. BNP Paribas Arbitrage SA raised its position in shares of K2M Group Holdings by 5,175.3% during the second quarter. BNP Paribas Arbitrage SA now owns 4,484 shares of the medical device company’s stock valued at $109,000 after buying an additional 4,399 shares during the last quarter. Rockefeller Financial Services Inc. acquired a new position in shares of K2M Group Holdings during the third quarter valued at about $105,000. Legal & General Group Plc raised its position in shares of K2M Group Holdings by 9.1% during the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock valued at $138,000 after buying an additional 564 shares during the last quarter. Dorsey & Whitney Trust CO LLC acquired a new position in K2M Group Holdings in the second quarter worth about $211,000. Finally, Symphony Asset Management LLC acquired a new position in K2M Group Holdings in the second quarter worth about $351,000. 99.92% of the stock is owned by institutional investors and hedge funds.
In other K2M Group Holdings news, insider John Philip Md Kostuik sold 1,332 shares of the stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $23.30, for a total value of $31,035.60. Following the sale, the insider now directly owns 200,629 shares in the company, valued at $4,674,655.70. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 5.80% of the company’s stock.
Several research analysts recently issued reports on KTWO shares. Cowen and Company reissued a “buy” rating and issued a $26.00 price target on shares of K2M Group Holdings in a research report on Wednesday, July 19th. BidaskClub raised shares of K2M Group Holdings from a “hold” rating to a “buy” rating in a research report on Wednesday, July 19th. Royal Bank Of Canada reissued a “buy” rating and issued a $26.00 price target on shares of K2M Group Holdings in a research report on Thursday, July 20th. Oppenheimer Holdings, Inc. set a $29.00 price target on shares of K2M Group Holdings and gave the stock a “buy” rating in a research report on Wednesday, August 2nd. Finally, Needham & Company LLC reissued a “buy” rating on shares of K2M Group Holdings in a research report on Wednesday, August 2nd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. K2M Group Holdings currently has an average rating of “Buy” and a consensus target price of $25.00.
Shares of K2M Group Holdings, Inc. (KTWO) opened at $18.42 on Thursday. The company has a quick ratio of 1.67, a current ratio of 3.06 and a debt-to-equity ratio of 0.29. K2M Group Holdings, Inc. has a twelve month low of $17.23 and a twelve month high of $25.99.
K2M Group Holdings (NASDAQ:KTWO) last posted its earnings results on Wednesday, November 1st. The medical device company reported ($0.20) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.19) by ($0.01). The firm had revenue of $62.65 million during the quarter, compared to analyst estimates of $62.69 million. K2M Group Holdings had a negative return on equity of 16.02% and a negative net margin of 16.22%. The company’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter last year, the business posted ($0.19) earnings per share. research analysts forecast that K2M Group Holdings, Inc. will post -0.86 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: “K2M Group Holdings, Inc. (KTWO) Shares Bought by Gabelli Funds LLC” was reported by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://www.dailypolitical.com/2017/11/16/k2m-group-holdings-inc-ktwo-shares-bought-by-gabelli-funds-llc.html.
K2M Group Holdings Profile
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.